The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Cavit Boz, Serkan Özakbaş, Murat Terzi, Rana Karabudak, Serhan Sevim, Recai Türkoğlu, Aysun Soysal, Belgin Petek Balcı, Hüsnü Efendi, Ömer Faruk Turan, Nur Yüceyar, Mehmet Fatih Yetkin, Serap Zengin Karahan, Meltem Demirkıran, Sibel Güler, Kadriye Ağan, Nefati Kıylıoğlu, Cavid Baba, Aslı Tuncer, Mesrure Köseoğlu
Topics & Concepts
FingolimodNatalizumabOcrelizumabMedicineMultiple sclerosisExpanded Disability Status ScaleInternal medicineRelapsing remittingPropensity score matchingRituximabImmunologyLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersVagus Nerve Stimulation Research